Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2017-11-10

New medicine for multiple sclerosis

View source ↗

Summary

EMA announces a new medicine for multiple sclerosis, indicating a new treatment option entering the European market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications